Immune-related adverse events with immune checkpoint inhibitors: Special reference to the effects on the lungs

Immune checkpoint inhibitors (ICIs) have emerged as evolutionary treatments for malignant diseases. Although ICIs can cause immune-related adverse events (irAEs) in various organs, precise timing after ICI initiation has been scarcely reported. Elucidating the effects of irAEs, such as time to onset...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirata, Aya, Saraya, Takeshi, Kobayashi, Fumi, Noda, Akinari, Aso, Kaori, Sakuma, Sho, Kurokawa, Nozomi, Inoue, Manami, Mikura, Sunao, Oda, Miku, Ishida, Manabu, Honda, Kojiro, Nakamoto, Keitaro, Tamura, Masaki, Takata, Saori, Ishii, Haruyuki, Takizawa, Hajime
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036099/
https://www.ncbi.nlm.nih.gov/pubmed/33832093
http://dx.doi.org/10.1097/MD.0000000000025275

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036099/
https://www.ncbi.nlm.nih.gov/pubmed/33832093
http://dx.doi.org/10.1097/MD.0000000000025275

Ejemplares similares